Exploring patterns in pediatric type 1 diabetes care and the impact of socioeconomic status

Christopher Nussbaum1,2, Anna Novelli3,4,5, Amelie Flothow3,4

  • 1Department of Health Economics, School of Medicine and Health, Technical University of Munich, Georg-Brauchle-Ring 60/62, Munich, 80992, Germany. Christopher.Buehler@tum.de.

BMC Medicine
|April 23, 2025
PubMed

Insights

Many children with type 1 diabetes receive suboptimal care, even with universal health coverage. Lower socioeconomic status is linked to significant gaps in guideline adherence and worse health outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Health Services Research
  • Diabetes Management

Background:

  • Pediatric type 1 diabetes management is complex, requiring significant parental involvement.
  • Lower socioeconomic status is linked to poorer outcomes in children with type 1 diabetes.
  • Limited research exists on the multidimensional, longitudinal care pathways of these children.

Purpose of the Study:

  • Identify latent clusters in pediatric type 1 diabetes care pathways.
  • Evaluate guideline adherence and disease management within identified clusters.
  • Assess the influence of socioeconomic status on cluster membership.

Main Methods:

  • Analyzed 3-year care pathways (2017-2019) of pediatric type 1 diabetes patients in Germany.
  • Utilized state sequence analysis and clustering algorithms (TraMineR R package) on health insurance claims data.
  • Compared observed care patterns against clinical guidelines to assess quality.

Main Results:

  • Identified two clusters: "guideline-adherent" and "care-with-gaps" (approx. 25% of cohort).
  • The "care-with-gaps" cluster showed significantly less guideline adherence (e.g., fewer HbA1c measurements) and higher hospitalization rates.
  • Lower parental education and unemployment predicted suboptimal care.

Conclusions:

  • A substantial number of pediatric type 1 diabetes patients in Germany receive suboptimal care, despite universal health coverage.
  • Gaps in glycemic diagnostics and complication screening contribute to adverse health outcomes.
  • Higher socioeconomic status correlates with better adherence to clinical guidelines.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
807
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
475
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
125
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
207